+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Drug Discovery Services Market Research Report by Process, by Type, by Drug Type, by Therapeutic Area - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 5146254
  • Report
  • September 2020
  • Region: Global
  • 158 pages
  • 360iResearch™
UP TO OFF
until Mar 31st 2021

Enquire about COVID-19 updates for this product.

Enquire Now
The Global Drug Discovery Services Market to Grow USD 19,028.57 Million by 2025, at a CAGR of 12.96%

FEATURED COMPANIES

  • Chempartner Co., Ltd.
  • Domainex Ltd.
  • Eurofins Scientific SE
  • Evotec SE
  • Frontage Holdings
  • Jubilant Life Sciences
The Global Drug Discovery Services Market is expected to grow from USD 9,158.49 Million in 2019 to USD 19,028.57 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 12.96%.

Market Segmentation & Coverage:

This research report categorizes the Drug Discovery Services to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Process, the Drug Discovery Services Market is examined across Candidate Validation, Hit-To-Lead Identification, Lead Optimization, Target Selection, and Target Validation.
  • Based on Type, the Drug Discovery Services Market is examined across Biology Services, Drug Metabolism & Pharmacokinetics, and Medicinal Chemistry Services.
  • Based on Drug Type, the Drug Discovery Services Market is examined across Biologic Drugs and Small-Molecule Drugs.
  • Based on Therapeutic Area, the Drug Discovery Services Market is examined across Cardiovascular Diseases, Digestive System Diseases, Neurology, and Oncology.
  • Based on Geography, the Drug Discovery Services Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Drug Discovery Services Market including Albany Molecular Research, Inc., Aurigene Discovery Technologies, Charles River Laboratories International, Chempartner Co., Ltd., Domainex Ltd., Eurofins Scientific SE, Evotec SE, Frontage Holdings, Genscript Biotech Corporation, Jubilant Life Sciences, Laboratory Corporation of America Holdings, Pharmaceutical Product Development, LLC, Piramal Enterprises Limited, Selvita, Shanghai Medicilon, Inc., Syngene International Limited, TCG Lifesciences Pvt. Limited, Thermo Fisher Scientific, Viva Biotech (Shanghai) Ltd., and Wuxi Apptec.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Drug Discovery Services Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. The ongoing research amplifies the research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Drug Discovery Services Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Discovery Services Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Discovery Services Market?
4. What is the competitive strategic window for opportunities in the Global Drug Discovery Services Market?
5. What are the technology trends and regulatory frameworks in the Global Drug Discovery Services Market?
6. What are the modes and strategic moves considered suitable for entering the Global Drug Discovery Services Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Chempartner Co., Ltd.
  • Domainex Ltd.
  • Eurofins Scientific SE
  • Evotec SE
  • Frontage Holdings
  • Jubilant Life Sciences
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Drug Type Outlook
3.5. Process Outlook
3.6. Therapeutic Area Outlook
3.7. Geography Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Growing R& D investments in the pharmaceutical & biopharmaceutical industry
5.2.2. Attractive rise in demand for outsourcing analytical testing and clinical trial services
5.2.3. Research on rare diseases and orphan drugs
5.3. Restraints
5.3.1. Expensive drug discovery and development
5.4. Opportunities
5.4.1. Development in the biologics and focus on drug discovery
5.4.2. Potential associated with expiry of patents
5.5. Challenges
5.5.1. Strict government rules for drug discovery and animal usage

6. Market Insights
6.1. Porters Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Customers
6.1.4. Bargaining Power of Suppliers
6.1.5. Industry Rivalry
6.2. Cumulative Impact of COVID-19
6.3. Client Customizations

7. Global Drug Discovery Services Market, By Process
7.1. Introduction
7.2. Candidate Validation
7.3. Hit-To-Lead Identification
7.4. Lead Optimization
7.5. Target Selection
7.6. Target Validation

8. Global Drug Discovery Services Market, By Type
8.1. Introduction
8.2. Biology Services
8.3. Drug Metabolism & Pharmacokinetics
8.4. Medicinal Chemistry Services

9. Global Drug Discovery Services Market, By Drug Type
9.1. Introduction
9.2. Biologic Drugs
9.3. Small-Molecule Drugs

10. Global Drug Discovery Services Market, By Therapeutic Area
10.1. Introduction
10.2. Cardiovascular Diseases
10.3. Digestive System Diseases
10.4. Neurology
10.5. Oncology

11. Americas Drug Discovery Services Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Drug Discovery Services Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. South Korea
12.10. Thailand

13. Europe, Middle East & Africa Drug Discovery Services Market
13.1. Introduction
13.2. France
13.3. Germany
13.4. Italy
13.5. Netherlands
13.6. Qatar
13.7. Russia
13.8. Saudi Arabia
13.9. South Africa
13.10. Spain
13.11. United Arab Emirates
13.12. United Kingdom

14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis
14.3. Market Share Analysis
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion

15. Company Usability Profiles
15.1. Albany Molecular Research, Inc.
15.2. Aurigene Discovery Technologies
15.3. Charles River Laboratories International
15.4. Chempartner Co., Ltd.
15.5. Domainex Ltd.
15.6. Eurofins Scientific SE
15.7. Evotec SE
15.8. Frontage Holdings
15.9. Genscript Biotech Corporation
15.10. Jubilant Life Sciences
15.11. Laboratory Corporation of America Holdings
15.12. Pharmaceutical Product Development, LLC
15.13. Piramal Enterprises Limited
15.14. Selvita
15.15. Shanghai Medicilon, Inc.
15.16. Syngene International Limited
15.17. TCG Lifesciences Pvt. Limited
15.18. Thermo Fisher Scientific
15.19. Viva Biotech (Shanghai) Ltd.
15.20. Wuxi Apptec

16. Appendix
16.1. Discussion Guide
Note: Product cover images may vary from those shown
  • Albany Molecular Research, Inc.
  • Aurigene Discovery Technologies
  • Charles River Laboratories International
  • Chempartner Co., Ltd.
  • Domainex Ltd.
  • Eurofins Scientific SE
  • Evotec SE
  • Frontage Holdings
  • Genscript Biotech Corporation
  • Jubilant Life Sciences
  • Laboratory Corporation of America Holdings
  • Pharmaceutical Product Development, LLC
  • Piramal Enterprises Limited
  • Selvita
  • Shanghai Medicilon, Inc.
  • Syngene International Limited
  • TCG Lifesciences Pvt. Limited
  • Thermo Fisher Scientific
  • Viva Biotech (Shanghai) Ltd.
  • Wuxi Apptec
Note: Product cover images may vary from those shown
Adroll
adroll